Handling HPAPIs safely – what does it take?
European Pharmaceutical Review
MARCH 9, 2023
There are emerging trends in oncology, with new chemical entities (NCEs) and antibody-drug conjugates (ADC) leading to increased demand for HPAPI manufacturing capabilities. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs).
Let's personalize your content